Retina Innovation Summit Logo-AI-01

Thomas M. Aaberg, Jr., MD, PhD

Thomas M. Aaberg, Jr., MD, PhD
Retina Specialists of Michigan / CMO - Neurotech

Caroline R. Baumal, MD

Caroline R. Baumal, MD
New England Eye Center, Tufts Medical Center

Robert B. Bhisitkul, MD, PhD

Robert B. Bhisitkul, MD, PhD
University of California San Francisco School of Medicine

Pierre Billardon

Pierre Billardon
DORC International B.V.
David Boyer, MD Retina Vitreous Associates Medical Group

David Boyer, MD

David Boyer, MD
Retina Vitreous Associates Medical Group  

Paul Bresge

Paul Bresge
Ray Therapeutics

Greg Butz

Greg Butz
Bank of America Merrill Lynch

Thomas Ciulla, MD, MBA

Thomas Ciulla, MD, MBA
Clearside Biomedical / Indiana University School of Medicine / Midwest Eye Institute

Eugene de Juan, MD

Eugene de Juan, MD
UCSF Department of Ophthalmology

Pravin U. Dugel, MD

Pravin U. Dugel, MD
Iveric Bio

David A. Eichenbaum, MD

David A. Eichenbaum, MD
Retina Vitreous Associates of Florida

David Esposito

David Esposito
ONL Therapeutics

Claire Gelfman, PhD

Claire Gelfman, PhD
Foundation Fighting Blindness

Shamika Gune, MD

Shamika Gune, MD
Genentech

Paul Hallen

Paul Hallen
Alcon

Erin Henry, PhD

Erin Henry, PhD
NGM Biopharmaceuticals

Nancy Holekamp, MD

Nancy Holekamp, MD
Pepose Vision Institute

J. Jill Hopkins, MD

J. Jill Hopkins, MD
Novartis

Jean-Pierre Hubschman, MD

Jean-Pierre Hubschman, MD
Stein Eye Institute at UCLA
Mark-Humayun

Mark Humayun, MD, PhD

Mark Humayun, MD, PhD
University of Southern California Roski Eye Institute
PAV

Peter Kaiser, MD

Peter Kaiser, MD
Cole Eye Institute

Jerry Lee, MBA

Jerry Lee, MBA
Goldman Sachs

James C. Murray

James C. Murray
ExSight Ventures

Aaron Nagiel, MD, PhD

Aaron Nagiel, MD, PhD
Keck School of Medicine of USC

John S. Pollack, MD

John S. Pollack, MD
Illinois Retina Associates / CMO - jCyte, Inc

Firas M. Rahhal, MD

Firas M. Rahhal, MD
ExSight Ventures & Retina Vitreous Associates Medical Group
Robert Rothman

Robert Rothman, MD

Robert Rothman, MD
InFocus Capital Partners /Glaucoma Consultants of Long Island
Russ Trenary

Russell Trenary

Russell Trenary
Outlook Therapeutics

Glenn C. Yiu, MD, PhD

Glenn C. Yiu, MD, PhD
UC Davis Health Department of Ophthalmology & Vision Science